Retractable (NYSE: RVP), a manufacturer and marketer of safety syringes and other innovative medical products for the health care industry, was recognized as the “Stock of the Year” for 2020 by The Bowser Report LLC. The report reads, “Unlike last year’s top pick [Repro Med Systems Inc. (NASDAQ: KRMD)], Retractable Technologies is a recent addition to the newsletter, named Company of the Month in January 2020. At the time, RVP was trading at $1.48. Just a couple of months after recommendation, the world and financial markets were shocked by the COVID-19 pandemic, which forced lockdowns, quarantines and stay-at-home orders. While this worldwide event was unforeseen, Retractable Technologies was positioned to and did succeed. As a result, RVP is 2020’s Stock of the Year.”
To view the full report, visit https://ibn.fm/9hkVV
About Retractable Technologies Inc.
Retractable manufactures and markets VanishPoint(R) and Patient Safe(R) safety medical products and the EasyPoint(R) needle. The VanishPoint syringe, blood collection and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes and prefilled syringes to give injections. The EasyPoint needle also can be used to aspirate fluids and for blood collection. Retractable’s products are distributed by various specialty and general line distributors. For more information about Retractable, visit its website at www.Retractable.com.
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork
